Skip to main content
. 2015 Jul 16;2:15023. doi: 10.1038/hgv.2015.23

Table 1. Japanese CM-SJS/TEN with SOC patients.

a. Association with PTGER3 SNPs
rs number of SNP Frequency of genotypes (%) Allele 1: major allele Allele 2: minor allele
Allele 1 versus allele 2 Genotype 11 versus 12+22 Genotype 11+12 versus 22
  Genotypes Cases Controls P valuea Corrected Pb OR (95% CI) P valuea Corrected Pb OR (95% CI) P valuea Corrected Pb OR (95% CI)
rs7555865 11 C/C 56/132 (42.4) 105/219 (47.9) 0.106 0.315 0.0772
  12 C/T 55/132 (41.7) 93/219 (42.5)      
  22 T/T 21/132 (15.9) 21/219 (9.59)      
               
rs17131450 11 C/C 97/132 (73.5) 194/221 (87.8) 1.22×10−4 6.36×10−4 0.0190
  12 C/T 30/132 (22.7) 26/221 (11.8) 2.20×10−3 0.0114 0.342
  22 T/T 5/132 (3.79) 1/221 (0.452) 0.379 (0.228–0.630) 0.386 (0.221–0.674) 0.115 (0.0133–0.999)
               
rs5702 11 C/C 87/131 (66.4) 109/221 (49.3) 0.0228 1.81×10−3 0.628
  12 C/T 32/131 (24.4) 95/221 (43.0) 0.410 0.0325  
  22 T/T 12/131 (9.16) 17/221 (7.69) 1.52 (1.06–2.17) 2.03 (1.30–3.18)  
               
rs1325949 11 A/A 91/132 (68.9) 105/221 (47.5) 1.94×10−3 8.86×10−5 0.950
  12 A/G 30/132 (22.7) 98/221 (44.3) 0.0349 1.59×10−3  
  22 G/G 11/132 (8.33) 18/221 (8.14) 1.77 (1.23–2.55) 2.45 (1.56–3.86)  
               
rs2421805 11 T/T 44/130 (33.8) 104/216 (48.1) 1.93×10−3 9.21×10−3 0.0108
  12 T/G 65/130 (50.0) 96/216 (44.4) 0.0348 0.166 0.194
  22 G/G 21/130 (16.2) 16/216 (7.41) 0.602 (0.436–0.831) 0.551 (0.351–0.865) 0.415 (0.208–0.829)
               
rs7543182 11 G/G 92/132 (69.7) 112/221 (50.7) 9.29×10−3 4.64×10−4 0.591
  12 G/T 29/132 (22.0) 94/221 (42.5) 0.167 8.36×10−3  
  22 T/T 11/132 (8.33) 15/221 (6.79) 1.63 (1.13–2.36) 2.24 (1.42–3.53)  
               
rs.7555874 11 G/G 91/132 (68.9) 112/221 (50.7) 0.0130 7.85×10−4 0.591
  12 G/A 30/132 (22.7) 94/221 (42.5) 0.234 0.0141  
  22 A/A 11/132 (8.33) 15/221 (6.79) 1.59 (1.10–2.30) 2.16 (1.37–3.40)  
               
rs4147115 11 A/A 45/128 (35.2) 54/212 (25.5) 0.0603 0.0569 0.291
  12 A/T 54/128 (42.2) 99/212 (46.7)      
  22 T/T 29/128 (22.7) 59/212 (27.8)      
               
rs4650093 11 C/C 84/132 (63.6) 113/220 (51.4) 0.129 0.0247 0.486
  12 C/T 37/132 (28.0) 93/220 (42.3)   0.445  
  22 T/T 11/132 (8.33) 14/220 (6.36)   1.66 (1.06–2.58)  
               
rs17131478 11 G/G 86/131 (65.6) 135/219 (61.6) 0.420 0.452 0.613
  12 G/T 41/131 (31.3) 75/219 (34.2)      
  22 T/T 4/131 (3.05) 9/219 (4.11)      
               
rs17131479 11 C/C 87/132 (65.9) 135/217 (62.2) 0.485 0.486 0.744
  12 C/G 41/132 (31.1) 74/217 (34.1)      
  22 G/G 4/132 (3.03) 8/217 (3.69)      
               
rs7521005 11 A/A 84/132 (63.6) 114/221 (51.6) 0.138 0.0273 0.479
  12 A/G 37/132 (28.0) 93/221 (42.1)   0.491  
  22 G/G 11/132 (8.33) 14/221 (6.33)   1.64 (1.06–2.56)  
               
rs7541092 11 G/G 86/131 (65.6) 136/218 (62.4) 0.488 0.540 0.608
  12 G/A 41/131 (31.3) 73/218 (33.5)      
  22 A/A 4/131 (3.05) 9/218 (4.13)      
               
rs1327464 11 G/G 83/131 (63.4) 194/219 (88.6) 7.92×10−10 1.90×10−8 1.23×10−3
  12 G/A 40/131 (30.5) 24/219 (11.0) 1.43×10−8 3.41×10−7 0.0221
  22 A/A 8/131 (6.11) 1/219 (0.457) 0.232 (0.142–0.381) 0.223 (0.129–0.385) 0.0705 (0.00872–0.571)
               
rs1409161 11 G/G 57/132 (43.2) 68/221 (30.8) 0.0988 0.0183 0.958
  12 G/A 52/132 (39.4) 114/221 (51.6)   0.329  
  22 A/A 23/132 (17.4) 39/221 (17.6)   1.71 (1.09–2.67)  
               
rs34885906 11 T/T 120/132 (90.9) 189/221 (85.5) 0.152 0.138
  12 T/C 12/132 (9.09) 32/221 (14.5)      
  22 C/C 0/132 (0.00) 0/221 (0.00)      
               
rs2817864 11 T/T 77/132 (58.3) 118/221 (53.4) 0.146 0.367 0.0352
  12 T/G 53/132 (40.2) 89/221 (40.3) 0.634
  22 G/G 2/132 (1.52) 14/221 (6.33) 4.40 (0.983–19.7)
               
rs1409981 11 G/G 37/131 (28.2) 60/218 (27.5) 0.874 0.884 0.664
  12 G/A 65/131 (49.6) 114/218 (52.3)      
  22 A/A 29/131 (22.1) 44/218 (20.2)      
b. Interaction between HLA-A*02:06 and PTGER3 rs1327464 GA/AA
HLA-A*02:06 rs1327464 GA or AA CM-SJS/TEN with SOC Controls P valuea OR (95% CI)
+ + 22/131 (16.8%) 4/218 (1.83%) 2.56×10−7 10.8 (3.63–32.1)
+ 39/131 (29.8%) 26/218 (11.9%) 3.38×10−5 3.13 (1.80–5.45)
+ 26/131 (19.9%) 21/218 (9.63%) 6.80×10−3 2.32 (1.25–4.33)
44/131 (33.6%) 167/218 (76.6%) 1.74×10−15 0.154 (0.0956–0.249)

Abbreviations: CI, confidence interval; CM-SJS, cold medicine-related Stevens–Johnson syndrome; OR, odds ratio; SOC, severe ocular complication; SNP, single-nucleotide polymorphism; TEN, toxic epidermal necrolysis.

a

P value for allele or genotype frequency. Comparison was between patients and controls using the chi-square test (Pearson).

b

Corrected P: P values corrected for the multiplicity of testing by the number of comparisons (n=18).

In table 1a, bold values denote P values that are significant after correction for the multiplicity of testing by the number of comparisons. In table 1b, bold value denotes OR with additive effect.